Evidence map›Paper›PMID 22710249›Full record

ArticleTuberculosis (Edinburgh, Scotland)2012

Rapid detection of Mycobacterium tuberculosis biomarkers in a sandwich immunoassay format using a waveguide-based optical biosensor.

Harshini Mukundan, Sandeep Kumar, Dominique N Price, Sonja M Ray, Ye-Jin Lee, Seonyeong Min, Seokyong Eum, Jessica Kubicek-Sutherland, Jesse M Resnick, W Kevin Grace and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00341601 (A Natural History Study of Multidrug-Resistant Tuberculosis Strains and Host Susceptibility Genes in Korean Patients With Pulmonary Tuberculosis), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00341601 completednot on this map

A Natural History Study of Multidrug-Resistant Tuberculosis Strains and Host Susceptibility Genes in Korean Patients With Pulmonary Tuberculosis

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2005 to 2018Enrolled777ConditionsTuberculosis
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Advanced Therapeutic Interventions TargetingArchives of Razi Institute · 2025
    Review
  7. Article
  8. Conditions for Handling and Optimal Storage of Mycolactone.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  9. Review
  10. Article
  11. Aptasensor for the Detection ofNanomaterials (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Pediatric Tuberculosis: The Impact of "Omics" on Diagnostics Development.International journal of molecular sciences · 2020
    Review
  16. Challenges and controversies in the treatment of spinal tuberculosis.Journal of clinical tuberculosis and other mycobacterial diseases · 2020
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Harshini MukundanChemistry Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA. Harshini@lanl.gov
Sandeep Kumar
Dominique N Price
Sonja M Ray
Ye-Jin Lee
Seonyeong Min
Seokyong Eum
Jessica Kubicek-Sutherland
Jesse M Resnick
W Kevin Grace
Aaron S Anderson
Soo Hee Hwang
Sang Nae Cho
Laura E Via
Clifton Barry
Ramamurthy Sakamuri
Basil I Swanson
Los Alamos National Laboratory · USInternational Tuberculosis Research Center · KRNational Institute of Allergy and Infectious Diseases · USMasan National Tuberculosis Hospital · KRNational Institutes of Health · USYonsei University · KR

Funding

International Research in Korea: Clinical Studies of Drug-Resistant TuberculosisZIAAI001067 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARRY, CLIFTON · 2009 to 2017
$6.9M
Intramural NIH HHS ZIA AI001067
6 · The paper itself

Abstract

Early diagnosis of active tuberculosis (TB) remains an elusive challenge, especially in individuals with disseminated TB and HIV co-infection. Recent studies have shown a promise for the direct detection of pathogen-specific biomarkers such as lipoarabinomannan (LAM) for the diagnosis of TB in HIV-positive individuals. Currently, traditional immunoassay platforms that suffer from poor sensitivity and high non-specific interactions are used for the detection of such biomarkers. In this manuscript, we demonstrate the development of sandwich immunoassays for the direct detection of three TB-specific biomarkers, namely LAM, early secretory antigenic target 6 (ESAT6) and antigen 85 complex (Ag85), using a waveguide-based optical biosensor platform. Combining detection within the evanescent field of a planar optical waveguide with functional surfaces that reduce non-specific interactions allows for the ultra-sensitive and quantitative detection of biomarkers (an order of magnitude enhanced sensitivity, as compared to plate-based ELISA) in complex patient samples (urine, serum) within a short time. We also demonstrate the detection of LAM in urine from a small sample of subjects being treated for TB using this approach with excellent sensitivity and 100% corroboration with disease status. These results suggest that pathogen-specific biomarkers can be applied for the rapid and effective diagnosis of disease. It is likely that detection of a combination of biomarkers offers greater reliability of diagnosis, rather than detection of any single pathogen biomarker. NCT00341601.

Indexed as

Biosensing TechniquesAcyltransferasesAntigens, BacterialBacterial ProteinsBiomarkersCoinfectionEnzyme-Linked Immunosorbent AssayFemaleHIV SeropositivityHumansImmunoassayLipopolysaccharidesMaleMycobacterium tuberculosisReagent Kits, DiagnosticReproducibility of ResultsAcyltransferasesantigen 85A, Mycobacterium tuberculosisAntigens, BacterialBacterial ProteinsBiomarkersESAT-6 protein, Mycobacterium tuberculosislipoarabinomannanLipopolysaccharidesReagent Kits, Diagnostic

Identifiers

PMID22710249
PMCPMC3432392
OpenAlexW2157297421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.